Director or Officer Departures, Elections, Appointments, and Compensation Arrangements

Business Context and Reporting Period

This Form 8-K filing by Ekso Bionics Holdings, Inc. (trading symbol: EKSO) reports on the Annual Meeting of Stockholders held on June 20, 2019, in Richmond, California. The filing details the outcomes of shareholder votes regarding director elections, equity plan amendments, executive compensation, and auditor ratification.

Key Financial Metrics

This filing is a current report regarding corporate governance events and does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The filing text does not provide a clear value for any financial indicators.

Material Changes and Voting Results

Of the 67,669,227 shares outstanding, 52,830,530 shares were present, constituting a quorum. The following material actions were approved:

  • Director Elections (Proposal 1): Stockholders approved the election of seven directors: Steven Sherman, Jack Peurach, Ted Wang, Marilyn Hamilton, Charles Li, Stanley Stern, and Thomas A. Schreck. All candidates received significant support, with votes withheld ranging from approximately 322,000 to 496,000 per director.
  • Equity Plan Increase (Proposal 2): Stockholders approved increasing the authorized shares under the 2014 Equity Incentive Plan from 9,114,285 to 12,614,285 shares. The vote was 27,129,573 For vs. 1,365,971 Against.
  • Executive Compensation (Proposal 3): The advisory vote on named executive officer compensation was approved with 27,266,541 votes For and 1,064,834 votes Against.
  • Auditor Ratification (Proposal 4): The appointment of OUM & Co., LLP as independent auditors for the year ending December 31, 2019, was ratified with 51,252,277 votes For and 786,324 votes Against.

Guidance, Outlook, and Risks

The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. The document is strictly limited to the reporting of the Annual Meeting results.

Investor Verification Checklist

  • Verify the new authorized share count for the 2014 Equity Incentive Plan (12,614,285 shares) to assess potential dilution.
  • Review the composition of the newly elected Board of Directors for changes in governance strategy.
  • Confirm the tenure of the newly ratified independent auditor, OUM & Co., LLP, for the 2019 fiscal year.
  • Note that this filing does not include financial results; refer to the most recent 10-K or 10-Q for financial performance data.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.